Reply to Comment: Is there any place for SGLT2-inhibitors in post-liver transplantation patients?

Affiliations

• ¹ Unit of Medicine and Metabolic Disease, Department of Pathophysiology and Transplantation Fondazione Ca' Granda IRCCS, Ospedale Maggiore Policlinico University of Milan, Milan, Italy. Electronic address: Giuseppina.pisano@policlinico.mi.it.
• ² Division of Gastroenterology and Hepatology, Unit of Transplant Hepatology, RC AM and A Migliavacca Center for the Study of Liver Disease, Fondazione Ca' Granda IRCCS, Ospedale Maggiore Policlinico, Italy.
• ³ Unit of Medicine and Metabolic Disease, Department of Pathophysiology and Transplantation Fondazione Ca' Granda IRCCS, Ospedale Maggiore Policlinico University of Milan, Milan, Italy.
• ⁴ Unit of Hepatic Surgery, Department of Pathophysiology and Transplantation, Fondazione Ca' Granda IRCCS, Ospedale Maggiore Policlinico University of Milan, Milan, Italy.
• ⁵ Endocrinology and Diabetes Unit, Ca' Granda IRCCS Foundation, Policlinico Hospital, Department of Medical Science, University of Milan, Italy.